Stockreport

Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment [Yahoo! Finance]

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Geneva, Switzerland, February 3, 2026 Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of n [Read more]